**Hims & Hers Health Expands European Footprint with Acquisition of Zava**

Hims & Hers Health announced on Tuesday that it will be acquiring European telehealth platform Zava. This strategic move is set to significantly broaden the company's reach, extending its services into Ireland, France, and Germany. The acquisition will also augment Hims & Hers' active customer base by approximately 50%, adding 1.3 million customers to the existing 2.4 million subscribers.

Scheduled to close by mid-year, the financial specifics of the deal were not shared, though details will be provided in subsequent financial disclosures. Hims & Hers CEO Andrew Dudum expressed enthusiasm for the acquisition, noting that it will not only accelerate European expansion but also facilitate entry into additional markets.

Dudum emphasized the importance of global expansion during the company's first-quarter earnings call in mid-May. He pointed to the company's initial success in the UK as an indicator of its potential to scale internationally. Hims & Hers made its first foray into the global market in 2021 by acquiring London-based Honest Health.

Zava CEO David Meinertz, who founded the platform in 2011, remarked on the deal's potential benefits for the European healthcare system. He noted that the competitive pricing of medications in Europe makes telehealth services more accessible and affordable, addressing growing demand amidst strains on public healthcare systems.

Post-acquisition, Zava will maintain its current branding for a few quarters before transitioning to the Hims & Hers brand. Meinertz will take on the role of general manager for the international business. Dudum acknowledged macroeconomic uncertainties but affirmed his confidence in the expansion strategy, highlighting the favorable pricing environment for pharmaceuticals in Europe compared to the U.S.